A phase I trial of Herceptin [trastuzumab] and interleukin-12

Trial Profile

A phase I trial of Herceptin [trastuzumab] and interleukin-12

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2013

At a glance

  • Drugs Interleukin-12 (Primary) ; Trastuzumab (Primary)
  • Indications Cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 25 Apr 2011 Additional lead trial centre added as reported by ClinicalTrials.gov.
    • 05 Mar 2009 Actual end date (1 Feb 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top